Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mutsuko Maekawa is active.

Publication


Featured researches published by Mutsuko Maekawa.


Mechanisms of Ageing and Development | 2000

Learning deficiency and alterations in acetylcholine receptors and protein kinase C in the brain of senescence-accelerated mouse (SAM)-P10

Yasunobu Okuma; Toshihiko Murayama; Kyi Kyi Tha; Chiharu Yamada; Masanori Hosokawa; Akiko Ishikawa; Ritsuko Watanabe; Mutsuko Maekawa; Yasuyuki Nomura

The senescence-accelerated mouse (SAM) is known to be a murine model for accelerated aging. A novel inbred SAMP10 has shown age-related brain atrophy and learning deficiency. In the present study, we investigated the changes in learning ability and in ligand binding with muscarinic acetylcholine (mACh) receptors, alpha adrenoceptors and protein kinase C in SAMP10. In Morriss water maze task, in a control strain of SAMR1 at 9 months, the escape latency and path length decreased with increasing trial days, in contrast, escape latency and path length did not decrease in SAMP10. These results indicate that SAMP10 exhibits learning deficiency. The ligand binding activity of mACh receptors decreased in the hippocampus of SAMP10 and the protein kinase C level in the hippocampus of SAMP10 was lower than that of SAMR1. On the other hand, there was no significant difference between SAMR1 and SAMP10 regarding ligand binding activity of alpha(1) and alpha(2) adrenoceptors. Thus, a reduction of mACh receptors and protein kinase C in the brain seems to underlie dysfunction of learning and memory in SAMP10.


Neurochemistry International | 2001

Involvement of noradrenaline transporters in S-nitrosocysteine-stimulated noradrenaline release from rat brain slices: existence of functional Na+-independent transporter activity

Mutsuko Maekawa; Toshihiko Murayama; Yasuyuki Nomura

Noradrenaline (NA) can be released by both exocytosis and by the membrane transporter responsible for transmitter uptake. Previously, we reported that S-nitrosocysteine (SNC), an S-nitrosothiol, stimulated [3H]NA release from the rat hippocampus. In this study, we investigated the involvement of the NA transport system in SNC-stimulated NA release from rat brain (cerebral cortex and hippocampus) slices. [3H]NA release by SNC in normal Na(+) (148 mM)-containing buffer from both slices was slightly, but significantly, inhibited by 1 microM desipramine, an NA transporter inhibitor. [3H]NA release in low Na(+) (under 14 mM)-containing buffer was inhibited by over 50% by desipramine. [3H]NA release by tyramine from both slices in normal and low Na(+) buffer was almost completely inhibited by desipramine. [3H]NA uptake into cerebral cortical slices was observed in low Na(+) buffer at 20-30% of normal Na(+) buffer levels. [3H]NA uptake in both normal and low Na(+) buffers was inhibited by desipramine and by SNC. Although [3H]NA uptake in normal Na(+) buffer was almost completely inhibited by 500 microM ouabain, the uptake in low Na(+) buffer was resistant to ouabain. These findings suggest the existence of a functional Na(+)-independent NA transport system and that SNC stimulates NA release at least partially via this system in brain slices.


Biochemical Pharmacology | 2000

Involvement of Hg2+-sensitive sulfhydryl groups in regulating noradrenaline release induced by S-nitrosocysteine in rat brain slices.

Mutsuko Maekawa; Souichi Satoh; Toshihiko Murayama; Yasuyuki Nomura

Nitric oxide has been shown to regulate neurotransmitter release. Previously, we reported that S-nitrosothiols such as S-nitrosocysteine (SNC) stimulate noradrenaline (NA) release in rat hippocampus in vivo and in vitro. To examine the role of sulfhydryl groups in SNC-induced NA release, the effects of metal ions such as Hg2+ and N-ethylmaleimide (NEM, a sulfhydryl alkylating agent) on [3H]NA release from labeled rat brain slices (hippocampus and cerebral cortex) were studied and compared with the effects of SNC. The addition of 200 microM HgCl2, but not Pb2+, Zn2+, or Cd2+, stimulated [3H]NA release from both types of slices in the presence of extracellular CaCl2. p-Chloromercuribenzoic acid (p-CMBA) also stimulated [3H]NA release. NEM stimulated [3H]NA release from both types of slices in the presence and absence of extracellular CaCl2. The effect of 200 microM NEM was enhanced, but the effect of 200 microM SNC was inhibited by co-addition of 200 microM p-CMBA in the absence of extracellular CaCl2. The concentration-response curve of SNC shifted to the right after co-addition of 200 microM p-CMBA or 100 microM HgCl2, although the effect of 200 microM NEM was additive to the effect of SNC. These findings demonstrate that SNC acts as a sulfhydryl agent on proteins that regulate NA release, and that SNC may share the same sulfhydryl groups with Hg compounds. The effect of T-588 ¿(R)-(-)-(benzo[b]thiophen-5-yl)-2-[2-(N,N-diethylamino)ethoxy]eth anol hydrochloride¿, a novel cognitive enhancer and a stimulator of NA release, was compared with the effects of sulfhydryl reagents.


Japanese Journal of Pharmacology | 1993

Protective Effect of R(-)-1-(Benzo [b]thiophen-5-yl)-2-[2-(N, N-diethylamino)ethoxy]ethanol Hydrochloride (T-588), a Novel Cerebral Activator, against Experimental Cerebral Anoxia

Satoshi Ono; Kazunori Kitamura; Mutsuko Maekawa; Kazunari Hirata; Motoko Ano; Wataru Ukai; Tetsuo Yamafuji; Hirokazu Narita


Biological & Pharmaceutical Bulletin | 1995

A New Cognition-Enhancing Agent, (R)-(-)-1-(Benzo [b] thiophen-5-yl)-2-[2-(N, N-diethylamino) ethoxy] ethanol Hydrochloride. Effects on Memory Impairment in Rats Generated by Cerebral Embolization and Basal Forebrain Lesions

Satoshi Ono; Tetsuo Yamafuji; Hisaaki Chaki; Yozo Todo; Mutsuko Maekawa; Kazunori Kitamura; Tatsuo Kimura; Yasushi Nakada; Kuniko Mozumi; Hirokazu Narita


Archive | 1990

1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same

Satoshi Ono; Tetsuo Yamafuji; Hisaaki Chaki; Mutsuko Maekawa; Yozo Todo; Hirokazu Narita


Archive | 1999

Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof

Satoshi Ono; Mutsuko Maekawa; Kazunari Hirata; Hirokazu Narita


Japanese Journal of Pharmacology | 1978

The mode of action of contractile effects induced by external calcium and its related bivalent cations in the KCl-depolarized rat uterus.

Masayasu Kimura; Ikuko Kimura; Mutsuko Maekawa


Japanese Journal of Pharmacology | 1998

The Effects of T-588, a Novel Cognitive Enhancer, on Noradrenaline Uptake and Release in Rat Cerebral Cortical Slices

Mutsuko Maekawa; Toshihiko Murayama; Satoshi Ono; Hirokazu Narita; Yasuyuki Nomura


Archive | 1995

Potentiator for nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof

Satoshi Ono; Mutsuko Maekawa; Kazunari Hirata; Hirokazu Narita

Collaboration


Dive into the Mutsuko Maekawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge